DR Profile
ReGen Therapeutics
Business Summary
Regen Therapeutics is engaged in the development of healthcare products both nutraceutical and ethical pharmaceuticals. Co. principal nutraceutical products is Colostrinin™.
Data provided by Mergent, Inc.Recent Company News
Powered by Interactive Data Managed Solutions
| DR Symbol | REGUY |
| CUSIP | 75885C105 |
| DR Exchange | OTC |
| DR ISIN | US75885C1053 |
| Ratio | 1:20 |
| Depositary | BK (Sponsored) |
| Effective Date | Dec 10, 2004 |
| Underlying ISIN | GB00B28XMY25 |
| Underlying SEDOL | B28XMY2 |
| Country | United Kingdom |
| Industry | Pharma. & Biotech. |
Monthly DR Trading Summary
| Month |
Month End DR Close Price |
DR Trading Volume |
Avg Day DR Trading Volume |
|---|---|---|---|
 Jun. 10 |
0.67 | n/a | n/a |
| May. 10 |
0.90 | n/a | n/a |
| Apr. 10 |
0.92 | n/a | n/a |
Related links
Custodians / BIC |
Helpful Links |
This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".
DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE
Please refer to "Terms Of Use".
DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE
